• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Combination Products

  • Print
  • Share
  • E-mail

Section Contents Menu

Meetings, Conferences, & Workshops

Agenda and Presentations

Public Hearing on:

FDA Regulation of Combination Products

Monday, November 25, 2002

 

AGENDA

--------------------------------------------------------------------------------

8:00 - 9:00

Doors Open

 

9:00 - 9:15

Opening Remarks

Mark Barnett

Murray Lumpkin, M.D.

 

9:15 - 9:30

American Academy of Orthopaedic Surgeons

Barbara D. Boyan, Ph.D.

Powerpoint Presentation

Text Version

 

9:30 - 9:45

Genetronics, Inc.

Paul Goldfarb, M.D.

Text Version

 

9:45 - 10:05

Angiogene, Inc.

Guy Chamberland, Ph.D.

Powerpoint Presentation

Text Version

 

10:05 - 10:20

Wyeth Pharmaceuticals, Inc.

F. Owen Fields, Ph.D.

Powerpoint Presentation

Text Version

 

10:20 - 10:30

Nephros Therapeutics, Inc.

Zorina Pitkin, Ph.D., RAC

Powerpoint Presentation

Text Version

 

10:30 – 10:45

Carnegie Mellon University

Mark Hamblin

Powerpoint Presentation

Text Version

 

10:45 – 11:00

BREAK

 

11:00 – 11:20

National Electrical Manufacturers Association

Terry Sweeney

Powerpoint Presentation

Text Version

 

11:20 – 11:30

Medical Imaging Contrast Agent Association

Alan Kirschenbaum, Esq.

Powerpoint Presentation

Text Version

 

11:30 – 11:45

Hogan & Hartson, LLP

David Fox

Powerpoint Presentation

Text Version

 

11:45 – 12:05

AdvaMed

Janet Trunzo or alternate

Patricia Shrader

Carolyn Jones

Daniel Troy ltr.

 

12:05 – 12:20

Aventis Behring

Michael Gross, Ph.D.

Powerpoint Presentation

Testimony

 

12:20 – 1:20

Open Microphone Session

(Members of the audience may make further brief comments as time permits)

 

1:20 – 1:30

Closing Remarks and Adjournment